Navigation Links
Marken Opens Two Pharmaceutical Depots In New York & Germany
Date:8/30/2012

RESEARCH TRIANGLE PARK, N.C., Aug. 30, 2012 /PRNewswire/ -- Marken announced today the completion of the first phase of its plan to create a global pharmaceutical depot network that will allow it to satisfy its clients' needs for global distribution. Two new depots have been completed:  one in Frankfurt, Germany and one in Farmingdale, New York. The launch of these two central depots, when added to the existing operational depots in Singapore, Mexico and Argentina and further supplemented by its own 3rd party depot network, now completes Phase I of the global Marken depot network plan. This network has been built based on an extensive analysis of client needs as well as geographical needs, allowing large Phase III clinical trials to be conducted in a cost efficient and optimized manner.

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

"Today marks an important milestone for Marken.  Having these two new central depots allows us to serve our clients with global distribution services and, more importantly, to serve our clients who seek comprehensive and efficient global distribution.  Phase One is complete.  We are now pushing forward with Phase Two, which will include more depots in key countries around the world such as China, Brazil and Russia," said Gerit Offenhauser, Senior Vice President, Clinical Trials Distribution for Marken.

Marken's depots provide secure temperature controlled storage and distribution for drugs, medical devices and diagnostic equipment.  They are located near existing branch operations in order to take advantage of well established customer service, operations import /export and administrative support. Each of Marken's depots are connected through the Solo platform, a state-of-the-art, 21 CFR part 11 validated, cloud based inventory management system which can interface with IRT for improved inventory reconciliation.  This interface allows our client to track dosages at the patient level.

Wes Wheeler, Chief Executive Officer of Marken, said, "We are proud to expand our pharmaceutical service depot network to Frankfurt and New York. Having a presence in these cities ensures that Marken continues to serve our clients with full service, global clinical supply chain solutions.  Marken will continue to invest in facilities and technologies which will provide the highest quality courier and logistics services."

About Marken

Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment in naive geographies.

www.marken.com


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Marken Launches Exclusive Shipping System for Specimen Logistics
2. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
3. CoreLab Partners Opens Office in Tokyo, Japan
4. Alchem International Opens Sales and Marketing Office in the U.S.
5. Stevenage Bioscience Catalyst Opens With Exciting Year Ahead
6. PRA Opens Office in Singapore
7. Discovery opens door to low-cost negative refraction, new products and industries
8. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
9. Data mining opens the door to predictive neuroscience
10. Scotland opens stem cell research center and bio-medical incubator
11. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:6/30/2017)... ARLINGTON, Va. , June 30, 2017 /PRNewswire-USNewswire/ ... a leading developer and supplier of face and ... the ATA Featured Product provider program. ... created an innovative way to monitor a driver,s ... benefit greatly from being able to detect fatigue ...
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/19/2017)... April 19, 2017 The global ... landscape is marked by the presence of several large ... held by five major players - 3M Cogent, NEC ... accounted for nearly 61% of the global military biometric ... in the global military biometrics market boast global presence, ...
Breaking Biology News(10 mins):